Enterprise Value

326M

Cash

68.6M

Avg Qtr Burn

N/A

Short % of Float

18.16%

Insider Ownership

1.90%

Institutional Own.

33.97%

Qtr Updated

03/31/23


Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & IndicationStage & EventCatalyst Date

Approved

Quarterly sales

Approved

Quarterly sales

Approved

Quarterly sales

Approved

Quarterly sales

INDOCIN Oral Suspension Details
RA (Rheumatoid arthritis)

Approved

Quarterly sales

Approved

Quarterly sales